|Year : 2015 | Volume
| Issue : 3 | Page : 336-343
Occurrence of blaNDM-1 & absence of blaKPC genes encoding carbapenem resistance in uropathogens from a tertiary care centre from north India
Balvinder Mohan, Vinaykumar Hallur, Gagandeep Singh, Harkiran Kaur Sandhu, Suma B Appannanavar, Neelam Taneja
Department of Medical Microbiology, Postgraduate Institute of Medical Education & Research, Chandigarh, India
|Date of Submission||01-May-2013|
|Date of Web Publication||6-Oct-2015|
Department of Medical Microbiology, Postgraduate Institute of Medical Education & Research, Chandigarh 160 012
Source of Support: None, Conflict of Interest: None
| Abstract|| |
Background & objectives: Carbapenem resistance mediated by carbapenemases is increasingly being reported worldwide. This study was conducted to know the occurrence of important carbapenem resistance encoding genes in Gram-negative bacilli (GNB) causing complicated urinary tract infection (CUTI), and to look at the genetic diversity of these isolates.
Methods: The study was carried out on 166 consecutive carbapenem resistant uropathogens (CRU) isolated from cases with CUTI during 2008 and 2012. Carbapenemase production was characterized phenotypically and polymerase chain reaction was used to detect bla VIM , bla IMP , bla KPC , and bla NDM-1 . BOX- PCR was done on 80 randomly selected isolates for molecular typing.
Results: The bla VIM gene was present in 34 (43.6%), bla IMP in five (6.4%) and none of the isolates from 2008 had bla NDM-1 or bla KPC genes. Among the isolates from 2012, bla NDM-1 gene was present in 47 (53.4%), bla VIM in 19 (24.4%), bla IMP in one (1.1%) and none had bla KPC . There were nine isolates during the two years which had multiple genes encoding carbapenemases; while 66 did not have any of the genes tested. Of the 80 isolates subjected to BOX-PCR, 58 could be used for analysis and showed, presence of multiple clusters of carbapenem resistant isolates and absence of a single dominant clone.
Interpretation & conclusions: The bla NDM-1 gene was absent in our isolates obtained during 2008 but was present amongst Enterobacteriaceae isolated in 2012. The bla KPC gene was also not found. Nine isolates obtained during the two years had multiple genes encoding carbapenemases confirming the previous reports of emergence of GNB containing genes encoding multiple carbapenemases. Typing using BOX-PCR indicated that this emergence was not because of clonal expansion of a single strain, and multiple strains were circulating at a single point of time.
Keywords: bla NDM-1 - blaKPC - carbapenem resistance - complicated urinary tract infection - uropathogens
|How to cite this article:|
Mohan B, Hallur V, Singh G, Sandhu HK, Appannanavar SB, Taneja N. Occurrence of blaNDM-1 & absence of blaKPC genes encoding carbapenem resistance in uropathogens from a tertiary care centre from north India. Indian J Med Res 2015;142:336-43
|How to cite this URL:|
Mohan B, Hallur V, Singh G, Sandhu HK, Appannanavar SB, Taneja N. Occurrence of blaNDM-1 & absence of blaKPC genes encoding carbapenem resistance in uropathogens from a tertiary care centre from north India. Indian J Med Res [serial online] 2015 [cited 2018 Mar 17];142:336-43. Available from: http://www.ijmr.org.in/text.asp?2015/142/3/336/166601
The carbapenems are β-lactam antibiotics that are used in the treatment of infections caused by extended spectrum beta-lactamases (ESBL) producing Gram-negative bacteria (GNB) and several serious bacterial infections like meningitis, nosocomial pneumonia, nosocomial sinusitis and sepsis of unknown origin. Resistance against carbapenems is mediated mainly by metallo-β-lactamases. A decade ago the genes encoding metallo-β-lactamases (MBL) were mainly present in the non-fermenting GNB like Pseudomonas aeruginosa and Acinetobacter species  . However, the latter data suggest that these have disseminated at an alarming rates to the members of family Enterobacteriaceae as has been seen with epidemics of blaKPC clones in USA, and Europe and the worldwide epidemic with blaNDM-1 producing Gram-negative bacteria . The New Delhi metallo β-lactamase (NDM-1) producing Escherichia coli and Klebsiella pneumoniae and other resistant GNBs, such as Acinetobacter species have been isolated more frequently from cases of urinary tract infection (UTI)  . This study was designed to observe the presence of the genes encoding important carbapenemases in uropathogens causing complicated urinary tract infection (CUTI) in a tertiary care centre in north India, and their genetic relatedness.
| Material & Methods|| |
The study was performed on carbapenem resistant uropathogens (CRU) isolated from patients with complicated urinary tract infection attending the outpatient department or admitted at the Nehru hospital of the Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India, during 2008 and 2012. Baseline prevalence of carbapenem resistant uropathogens was obtained from laboratory records maintained during 2008 and 2012. Complicated UTI was defined as infection developing in a patient with anatomically, physiologically or functionally compromised urinary tract  .
Bacterial isolates: A total of 166 non-duplicate consecutive carbapenem resistant uropathogens were collected over a period of two years (between 1 st May to 31 st August in 2008 and 2012) from patients with complicated UTI. All the isolates were identified using standard conventional biochemical tests. Antibiotic susceptibility was performed using the Kirby Bauer disc diffusion method  and results were interpreted as per the Clinical and Laboratory Standards Institute (CLSI) guidelines  . The antibiotic discs were obtained from Hi-media, Mumbai, India. Only those isolates that had a reduced susceptibility to meropenem (zone size ≤21 mm) and were found to produce carbapenemases and metallo-beta-lactamases by using both modified Hodge test and double disc synergy test were included in this study  . Briefly, the indicator organism, E. coli ATCC 25922, at a turbidity of 0.5 McFarland standard, was used to swab inoculate the surface of a Mueller-Hinton agar (Hi-Media, Mumbai, India) plate, and the test strain was heavily streaked from the plate centre to the periphery. After the plate was allowed to stand for 15 min at room temperature, a 10 µg imipenem disc (Hi-Media) was placed at the centre, and the plate was incubated overnight. The presence of a distorted inhibition zone was interpreted as a positive result for carbapenem hydrolysis screening. The detection of mβ0 L production was also performed by the combined-disc test by using two imipenem discs (10 μg), one containing 10 μl of 0.5 M EDTA (SRL Laboratories, India), which were placed 25 mm apart on a Mueller-Hinton agar plate .
Molecular detection of carbapenemase genes: Polymerase chain reaction (PCR) was performed for blaIMP (detects all imipenems except IMP-9, IMP-16, IMP-18, IMP-22 and IMP-25), blaVIM, blaKPC and blaNDM-1 to identify the presence of the resistance genes, using the primers described in [Table 1] , . Total DNA (2 µl) was subjected to PCR in a 25 µl reaction mixture containing 1x PCR buffer, 0.4mM dNTP(Bangalore Genei, India), 0.6 µM each of forward and reverse primers (Sigma Aldrich, India), and 1 U of Taq polymerase (Bangalore Genei, India). Amplification was carried out as follows: initial denaturation at 94°C for 10 min; 30 cycles of 94°C for 40 sec, 55°C for 40 sec and 72°C for one min; and a final elongation step at 72°C for seven min. The annealing temperature was 55°C for blaIMP and 58°C blaVIM , and blaNDM-1 genes. A 100 bp DNA ladder was used as a size marker. Amplicons were visualized after running at 90V for one hour on a 2 per cent agarose gel containing ethidium bromide in a gel documentation system (Alpha Innotech, AlphaImager 3400).
Molecular typing of the carbapenem resistant uropathogens: Of the 166 isolates, 80 were chosen randomly for molecular typing using BOX PCR using the primer BOX-A1R primer (5`-CTACGGCAAGGCGACGCTGACG-3`) as described elsewhere  . Briefly, 500 ng of DNA was added to
25 µl reaction mixture containing 2.5 µl of PCR buffer with 1.5 mM MgCl 2 , 0.8 µl of dNTPs, 2.25 µl of primer, 0.5 µl of Taq polymerase and PCR grade water. Amplification was carried out as follows: initial denaturation for two min at 94°C, 30 cycles of 94°C for 30 sec, 55°C for one min and 72°C for eight min; and a final elongation step at 72°C for eight min. Further steps till visualisation of the bands were the same as for PCR. The gel images were imported into Bionumerics 7.1 (Applied Maths NV, Belgium). E. aerogenes, Morganella morganii, Proteus mirabilis and Providencia stuartii were excluded from BOX PCR as the total number of individual isolates was < 10. Only those isolates with ≥ 7 bands (between 100 and 1500 bp) were included for analysis. Dendrogram was constructed using the band based UPGMA protocol  . The experiment was repeated twice.
Statistical analysis: The chi square test was applied to compare different proportions of samples and/or cases of complicated UTI during 2008 and 2012.
| Results|| |
High carbapenem resistance was observed amongst Enterobacteriaceae and non-fermenting GNBs during 2008 (9.3 and 61.6%) and 2012 (12.3 and 43.8%)
[Table 2]. A total of 166 carbapenem resistant uropathogens which were isolated between May to August 2008 and 2012 at our centre, were analysed. Majority (57, 73.1%) of the isolates from 2008 were non-fermenting GNB and the rest (21, 26.9%) belonged to the family Enterobacteriaceae. Among the 88 isolates from 2012, 51 (58%) were members of family Enterobacteriaceae and 37 (42%) were non-fermenting GNB. In 2008 isolates the blaVIM gene was present in 34 isolates (43.6%), blaIMP gene was present in five (6.4%) and none had blaNDM-1 or blaKPC gene. There were two isolates from 2008 which had both blaVIM and blaIMP genes. Among the isolates obtained during 2012, blaNDM-1 gene was present in 47 (53.4% of total and 84.3% of Enterobacteriaceae), blaVIM in 19 (24.4%), and blaIMP in one isolate. Six isolates from 2012 had blaVIM and blaNDM-1 genes, while a single isolate with blaIMP gene also had blaNDM-1 gene. Forty one (52.6%) and 25 isolates (28.4%) from 2008 and 2012 did not have any of the genes tested [Table 3].
|Table 2. Details used to calculate baseline carbapenem resistance in isolates from cases of urinary tract infection (UTI) |
Click here to view
|Table 3. Beta lactamase gene profile of different carbapenem resistant Enterobacteriaceae (CRE) isolates obtained during 2008 and 2012 |
Click here to view
Of the 80 isolates randomly selected for typing, 25 were P. aeruginosa, 20 were E. coli, 20 were K. pneumoniae, and 15 belonged to A. baumannii complex. Only 58 (21 P. aeruginosa, 13 E. coli, 17 K. pneumoniae, and 7 A. baumannii complex) from the above had > 10 bands (between 100-1500 bp) and were analysed. The dendrogram is shown in the [Figure 1]. A cluster of possibly related isolates was defined as isolates having more than 70 per cent similarity, while those having similarity of >90 per cent were considered as closely related. Accordingly, it was found that there was no clustering among the Acinetobacter spp. Six possibly related clusters (PA1 to PA 6) were seen among the P. aeruginosa isolates; PA 4, PA 5 and PA 6 contained isolates only from 2008, while PA1, PA2 and PA3 had isolates from 2008 and 2012. Three and four possibly related clusters each were found among K. pneumoniae and E. coli isolates. It was seen that the isolates did not cluster according to the year of isolation among K. pneumoniae. While, the same was true for E. coli, except in cluster EC 3 which contained isolates only from 2012. Two closely related isolates were found in each of the following clusters: PA6, PA4, PA2, PA3, EC3, and KP2. Similarly, four closely related isolates were found in cluster PA1.
|Figure 1. UPGMA (unweighted pair group method with arithmetic mean) tree fo BOX-PCR patterns from 58 carbapenem resistant uropathogens isolated during 2008 and 2012|
Click here to view
| Discussion|| |
In view of the increasing reports of carbapenem resistant pathogens from India and lack of data regarding the scenario in carbapenem resistant uropathogens isolated from cases of complicated UTI, this study was done to know the occurrence of commonly occurring carbapenemase encoding genes in the above and to study the genetic relatedness between these isolates.
High carbapenem resistance was found among uropathogens at our centre. It was observed that carbapenemase resistance which was a problem in non-fermenters, became more common in Enterobacteriaceae during 2012, and majority of our isolates that fulfilled the criteria of carbapenem resistance in 2008 were non-fermenting GNB while members of the family Enterobacteriaceae (83.60%) formed the bulk of carbapenem resistant isolates during 2012. A number of methods like modified Hodge test, double disc synergy test, molecular detection of carbapenemase encoding genes are available for detection of carbapenem resistance in GNB. Since, there are no uniform guidelines for detection of carbapenemase production among GNB; we performed both modified Hodge test and double disc synergy test simultaneously  . Only those isolates positive by both the tests were included in the study.
There have been several reports of GNB producing carbapenemases from both India and abroad. The most common among them being imipenem hydrolysing enzyme (IMP), Verona integron encoded metallo beta lactamase (VIM), Klebsiella pneumoniae carbapenemase (KPC) and New Delhi metallo beta-lactamase-1 (NDM-1) encoded by blaIMP , blaVIM , blaKPC and blaNDM-1 genes, respectively ,, . The blaNDM-1 gene was first described in 2008 in a Klebsiella isolate obtained from a patient in Sweden who had been previously hospitalized in New Delhi  . Castenheira et al reported the presence of blaNDM-1 (15 out of 39 CRE, 38.5%) and its dissemination in Indian CRE isolated between 2006-2007. Several reports have been published on the presence of this gene in non-fermenters both from India and abroad ,, . However, none of the CRUs isolated during 2008 in our study had blaNDM-1 gene, though, it was the commonest carbapenem encoding gene in carbapenem resistant Enterobacteriaceae (CRE) isolated during 2012. We also found four isolates of P. Aeruginosa obtained during 2012 having blaNDM-1 gene. Such a high occurrence of blaNDM-1 indicates an endemic occurrence and appearance and rapid spread of this gene after 2008 in northwest India.
KPC carbapenemase was first reported from United States of America during 2001. These were virtually resistant to all antibiotics and spread rapidly globally  . A prevalence of 34.8 per cent of blaKPC has been reported by Lascols et al in CRE isolated from intra-abdominal infection from India. However, in our study none of our isolates were positive for blaKPC . Our finding was in agreement with that of Nagaraj et al who also did not find blaKPC in any of their crE.
The blaIMP gene first detected in the 1980s in Japan and subsequently reported worldwide  , was the least common gene detected during 2008 and 2012 in our study. This finding was in agreement with that of Amudhan et al who also found a low level of blaIMP during 2010. However, it was contrary to the findings of Dwivedi et al who reported an occurrence of blaIMP in seven out of 12 carbapenem resistant Enterobacteriaceae isolated in 2005 and 2006. This could be due to differences in the local circulating strains and not due to differences in type of clinical samples since prior antibiotic therapy which is a risk factor for the development of carbapenemase production was present in both patients of ventilator associated pneumonia (VAP), complicated UTI and hospitalized patients ,, .
Among the non-fermenters blaVIM was the commonest gene detected both during 2008 and 2012. This finding was similar to that reported earlier , . Forty one (52.6%) and 25 (28.4%) isolates obtained during 2008 and 2012, respectively did not have any of the genes tested for by PCR. The carbapenem resistance was possibly mediated by other genes not tested in the present study (e.g. GES, OXA-48, PER and VEB) or other mechanisms like absence of OprD which diminishes the permeability of cell wall to carbapenems, or presence of efflux pumps and altered penicillin binding proteins ,, .
Molecular typing of the isolates was done using BOX-PCR technique. It is a type of repetitive element palindromic-PCR, which has been previously used for typing of both Gram-positive and Gram-negative organisms ,, . In previous studies, it was found to be rapid and have similar discriminatory capability as pulse field gel electrophoresis (PFGE) , . We found that there were multiple clusters of possibly related isolates, though there was no evidence for a single dominant clone. Our study also demonstrated that multiple clusters of possibly related strains were circulating at a particular point of time and some which were present in 2008, were also obtained in 2012, showing the persistence of some closely related strains. In this study, an increased carbapenem resistance was found among the members of Enterobacteriaceae from 2008 to 2012, which was mainly due to carbapenemases encoded on plasmids. These carbapenemases have a potential to be transferred both intra- and intergenically. Hence, this calls for better infection control measures and continued surveillance for carbapenem resistance.
| Acknowledgment|| |
The authors acknowledge Ms. Monica Österblad, Research Scientist, Antimicrobial Resistance Unit, Department of Infectious Disease Surveillance and Control, National Institute for Health and Welfare, Turku, Finland for providing K. pneumoniae strains for standardizing the polymerase chain reaction for blaKPC gene.
| References|| |
Shanthi M, Sekar U. Multi-drug resistant Pseudomonas aeruginosa
and Acinetobacter baumannii
infections among hospitalized patients: risk factors and outcomes. J Assoc Physicians India
Nordmann P, Naas T, Poirel L. Global spread of carbapenemase-producing Enterobacteriaceae
. Emerg Infect Dis
Nicolle LE. Update in adult urinary tract infection. Curr Infect Dis Rep
Taneja N, Singh G, Singh M, Madhup S, Pahil S, Sharma M. High occurrence of blaCMY-1
AmpC lactamase producing Escherichia coli
in cases of complicated urinary tract infection (UTI) from a tertiary health care centre in north India. Indian J Med Res
Bauer AW, Kirby WM, Sherris JC, Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol
Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing
; 18 th
Informational Supplement, M100-S18, vol. 28, no. 1. Wayne, PA; USA: CLSI; 2008.
Lee K, Chong Y, Shin HB, Kim YA, Yong D, Yum JH. Modified Hodge and EDTA-disk synergy tests to screen metallo-beta-lactamase-producing strains of Pseudomonas
species. Clin Microbiol Infect
Dallenne C, Da Costa A, Decre D, Favier C, Arlet G. Development of a set of multiplex PCR assays for the detection of genes encoding important beta-lactamases in Enterobacteriaceae
. J Antimicrob Chemother
Nordmann P, Boulanger AE, Poirel L. NDM-4 metallo-beta-lactamase with increased carbapenemase activity from Escherichia coli
. Antimicrob Agents Chemother
Proudy I, Bougle D, Coton E, Coton M, Leclercq R, Vergnaud M. Genotypic characterization of Enterobacter sakazakii
isolates by PFGE, BOX-PCR and sequencing of the fliC
gene. J Appl Microbiol
Croxall G, Weston V, Joseph S, Manning G, Cheetham P, McNally A. Increased human pathogenic potential of Escherichia coli
from polymicrobial urinary tract infections in comparison to isolates from monomicrobial culture samples. J Med Microbiol
Miriagou V, Cornaglia G, Edelstein M, Galani I, Giske CG, Gniadkowski M, et al.
Acquired carbapenemases in Gram-negative bacterial pathogens: detection and surveillance issues. Clin Microbiol Infect
Kumarasamy KK, Toleman MA, Walsh TR, Bagaria J, Butt F, Balakrishnan R, et al.
Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis
Nagaraj S, Chandran SP, Shamanna P, Macaden R. Carbapenem resistance among Escherichia coli
and Klebsiella pneumoniae
in a tertiary care hospital in south India. Indian J Med Microbiol
Amudhan MS, Sekar U, Kamalanathan A, Balaraman S. bla
(IMP) and bla
(VIM) mediated carbapenem resistance in Pseudomonas
species in India. J Infect Dev Ctries
Yong D, Toleman MA, Giske CG, Cho HS, Sundman K, Lee K, et al.
Characterization of a new metallo-beta-lactamase gene, bla NDM-1
, and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae
sequence type 14 from India. Antimicrob Agents Chemother
Castanheira M, Deshpande LM, Mathai D, Bell JM, Jones RN, Mendes RE. Early dissemination of NDM-1- and OXA-181-producing Enterobacteriaceae
in Indian hospitals: report from the SENTRY Antimicrobial Surveillance Program, 2006-2007. Antimicrob Agents Chemother
Bharadwaj R, Joshi S, Dohe V, Gaikwad V, Kulkarni G, Shouche Y. Prevalence of New Delhi metallo-beta-lactamase (NDM-1)-positive bacteria in a tertiary care centre in Pune, India. Int J Antimicrob Agents
Jovcic B, Lepsanovic Z, Suljagic V, Rackov G, Begovic J, Topisirovic L, et al.
Emergence of NDM-1 metallo-beta-lactamase in Pseudomonas aeruginosa
clinical isolates from Serbia. Antimicrob Agents Chemother
Walsh TR, Weeks J, Livermore DM, Toleman MA. Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study. Lancet Infect Dis
Kitchel B, Rasheed JK, Patel JB, Srinivasan A, Navon-Venezia S, Carmeli Y, et al.
Molecular epidemiology of KPC-producing Klebsiella pneumoniae
isolates in the United States: clonal expansion of multilocus sequence type 258. Antimicrob Agents Chemother
Lascols C, Hackel M, Marshall SH, Hujer AM, Bouchillon S, Badal R, et al.
Increasing prevalence and dissemination of NDM-1 metallo-beta-lactamase in India: data from the SMART study (2009). J Antimicrob Chemother
Watanabe M, Iyobe S, Inoue M, Mitsuhashi S. Transferable imipenem resistance in Pseudomonas aeruginosa
. Antimicrob Agents Chemother
Dwivedi M, Mishra A, Azim A, Singh RK, Baronia AK, Prasad KN, et al.
Ventilator-associated pneumonia caused by carbapenem-resistant Enterobacteriaceae
carrying multiple metallo-beta-lactamase genes. Indian J Pathol Microbiol
Brink A, Coetzee J, Clay C, Corcoran C, van Greune J, Deetlefs JD, et al.
The spread of carbapenem-resistant Enterobacteriaceae
in South Africa: risk factors for acquisition and prevention. S Afr Med J
Castanheira M, Bell JM, Turnidge JD, Mathai D, Jones RN. Carbapenem resistance among Pseudomonas aeruginosa
strains from India: evidence for nationwide endemicity of multiple metallo-beta-lactamase clones (VIM-2, -5, -6, and -11 and the newly characterized VIM-18). Antimicrob Agents Chemother
Kohler T, Michea-Hamzehpour M, Epp SF, Pechere JC. Carbapenem activities against Pseudomonas aeruginosa
: respective contributions of OprD and efflux systems. Antimicrob Agents Chemother
Ballestero S, Fernandez-Rodriguez A, Villaverde R, Escobar H, Perez-Diaz JC, Baquero F. Carbapenem resistance in Pseudomonas aeruginosa
from cystic fibrosis patients. J Antimicrob Chemother
Tacao M, Alves A, Saavedra MJ, Correia A. BOX-PCR an adequate tool for typing Aeromonas
spp. Antonie Van Leeuwenhoek
van Belkum A, Hermans PW. BOX PCR fingerprinting for molecular typing of Streptococcus pneumoniae
. Methods Mol Med
Liakopoulos A, Mavroidi A, Katsifas EA, Theodosiou A, Karagouni AD, Miriagou V, et al.
Carbapenemase-producing Pseudomonas aeruginosa
from central Greece: molecular epidemiology and genetic analysis of class I integrons. BMC Infect Dis
Hahm BK, Maldonado Y, Schreiber E, Bhunia AK, Nakatsu CH. Subtyping of foodborne and environmental isolates of Escherichia coli
by multiplex-PCR, rep-PCR, PFGE, ribotyping and AFLP. J Microbiol Methods
Syrmis MW, O'Carroll MR, Sloots TP, Coulter C, Wainwright CE, Bell SC, et al.
Rapid genotyping of Pseudomonas aeruginosa
isolates harboured by adult and paediatric patients with cystic fibrosis using repetitive-element-based PCR assays. J Med Microbiol
[Table 1], [Table 2], [Table 3]
|This article has been cited by|
||Drug-resistant gram-negative uropathogens: A review
| ||Saeed Khoshnood,Mohsen Heidary,Reza Mirnejad,Aghil Bahramian,Mansour Sedighi,Habibollah Mirzaei |
| ||Biomedicine & Pharmacotherapy. 2017; 94: 982 |
|[Pubmed] | [DOI]|
||Clinical outcome of dual colistin- and carbapenem-resistant Klebsiella pneumoniae bloodstream infections: A single-center retrospective study of 75 cases in India
| ||Amarjeet Kaur,Sumanth Gandra,Priyanka Gupta,Yatin Mehta,Ramanan Laxminarayan,Sharmila Sengupta |
| ||American Journal of Infection Control. 2017; |
|[Pubmed] | [DOI]|